Examples of using Was comparable in English and their translations into Croatian
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
The magnitude of analgesic effect of the 40 mg dose was comparable with that of ketorolac 60 mg IM
Veličina analgetskog učinka doze od 40 mg bila je usporediva s učinkom ketorolaka u dozi od 60 mg i.m.Apparent clearance per kg body weight(CL/F per kg) was comparable between the SJIA and CAPS population 0.004 l/d per kg.
Prividni klirens po kg tjelesne težine(CL/F po kg) bio je usporediv između populacije sa SJIA-om i one sa CAPS-om 0, 004 l/d po kg.At month 12, reduction in tumour volume was comparable between the treatment groups
U 12. mjesecu smanjenje u volumenu tumora bilo je usporedivo između terapijskih skupinathe frequency of bleeding in both treatment arms was comparable see section 4.8.
učestalost krvarenja u obje liječene skupine bila je usporediva vidjeti dio 4.8.Discontinuation of therapy due to adverse events was comparable in patients who received placebo
Prekid liječenja zbog štetnih događaja bio je usporediv u bolesnika koji In general, the adverse event profile reported with overdose was comparable to that observed with recommended doses of RotaTeq.
Profil štetnih događaja prijavljenih kod predoziranja općenito je bio usporediv s onim primijećenim kod primjene preporučenih doza cjepiva RotaTeq.In studies, Cresemba's effect was comparable to that of voriconazole in treating invasive aspergillosis.
Djelovanje lijeka Cresemba tijekom ispitivanja bilo je usporedivo s djelovanjem vorikonazola u liječenju invazivne aspergiloze.Paliperidone systemic exposure in adolescent subjects(15 years and older) was comparable to that in adults.
Sistemska izloženost paliperidonu u ispitanika adolescenata(od 15 godina i starijih) bila je usporediva s onom u odraslih.During the development programme, the safety profile of MabThera subcutaneous formulation was comparable to that of the intravenous formulation with the exception of local cutaneous reactions.
Tijekom razvojnog programa, sigurnosni profil formulacije lijeka MabThera za supkutanu primjenu bio je usporediv sa sigurnosnim profilom formulacije za intravensku primjenu, uz izuzetak lokalnih kožnih reakcija.Ponatinib Cmax was comparable in patients with mild hepatic impairment
as assessed by AUC(0-24), was comparable to that noted for the same doses in the adult population.
procijenjena na temelju AUC(0-24), bila je usporediva s izloženošću u odraslih ispitanika kod primjene iste doze.In the study, the risk of olanzapine was comparable to the risk of atypical antipsychotics included in a pooled analysis.
U ispitivanju rizik olanzapina bio je usporediv s rizikom za atipične antipsihotike uključene u skupnu analizu.The alpha half-life approximated 4-5 days and was comparable between courses leading to low
Alfa poluvijek iznosio The frequency of treatment emergent hepatitis or transaminase elevations in co-infected patients was comparable between atazanavir and comparator regimens see section 4.4.
Učestalost hepatitisa ili povišenja razine transaminaza koji The ECOG performance status was comparable between both groups, as was the number
Status funkcionalnog stanja prema ljestvici ECOG bio je usporediv između obje skupine kao i brojThe ECOG performance status was comparable between both groups, as was the number of prior therapies.
Funkcionalni status ECOG bio je sličan u obje skupine, kao i broj prijašnjih terapija.the evaluation period(week 21-28)] was comparable between the two groups.
perioda procjene(tjedan 21-28)] bila je usporediva između dvije skupine.The onset of action of Brimica Genuair was comparable to the effect of the fast-acting β2-agonist formoterol 12 micrograms.
Nastup djelovanja Brimica Genuaira bio je usporediv s učinkom brzodjelujućeg β2-agonista formoterola u dozi od 12 mikrograma.at week 96 was comparable between the rilpivirine arm
50 HIV-1 RNA kopija/ml) u 96. tjednu bila je usporediva između skupine liječene rilpivirinomThe safety profile of the combined use of saxagliptin plus dapagliflozin plus metformin was comparable to the adverse reactions identified for the respective mono-components.
Sigurnosni profil kombinirane primjene saksagliptina plus dapagliflozin plus metformin bio je usporediv s nuspojavama utvrđenima kod primjene tih sastavnica kao monokomponenti.
